Showing results (551-560 of 815) with videos related to
Sort By:
Pageof 82
The Ocular Surface|February 21, 2021
Effect of therapeutic UVC on corneal DNA: Safety assessment for potential keratitis treatmentSanjay Marasini, Odunayo O Mugisho, Simon Swift, et al.The Journal of Arthroplasty|February 8, 2025
A Workflow-Efficient Approach to Pre- and Post-Operative Assessment of Weight-Bearing Three-Dimensional Knee KinematicsScott A Banks, Gokce Yildirim, George Jachode, et al.Cellular Immunology|September 20, 2005
Immunochemical analysis of CD107a (LAMP-1)Emma J Parkinson-Lawrence, Caroline J Dean, Melissa Chang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
Substance P receptor antagonist I: conversion of phosphoramidate prodrug after i.v. administration to rats and dogsS E Huskey, D Luffer-Atlas, B J Dean, et al.British Journal of Haematology|August 25, 1999
Haemochromatosis mutations in North-East ScotlandZ Miedzybrodzka, S Loughlin, D Baty, et al.Journal of Structural Biology|July 27, 2001
Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formationR Lyons Ryall, D E Fleming, I R Doyle, et al.Cell Biophysics|January 1, 1993
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancerC J Dean, S A Eccles, M Valeri, et al.Cancer Research|October 1, 1994
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185S A Eccles, W J Court, G A Box, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Nabilone: a potent antiemetic cannabinol with minimal euphoriaT S Herman, S E Jones, J Dean, et al.Psycho-Oncology|June 27, 2009
Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional roleThomas F Hack, Tom Pickles, J Dean Ruether, et al.Pageof 82